Together we will improve health outcomes worldwide.
CRISPR-based detection methods have received substantial attention for nucleic acid-based molecular testing due to their simplicity, high sensitivity, and specificity. This is essential to ending the pandemic now, and to strengthening global health security for tomorrow—to better prevent, detect, and respond to the next threat. That’s why we are partnering with leading organizations to develop and commercialize tests using Engineering Biology technologies. We work alongside partners to rapidly develop better tests and put them in the hands of more people.